0000950170-24-041843.txt : 20240404
0000950170-24-041843.hdr.sgml : 20240404
20240404163045
ACCESSION NUMBER: 0000950170-24-041843
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240402
FILED AS OF DATE: 20240404
DATE AS OF CHANGE: 20240404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lim Jonathan E
CENTRAL INDEX KEY: 0001283290
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41989
FILM NUMBER: 24823524
MAIL ADDRESS:
STREET 1: 11588 SORRENTO VALLEY ROAD, SUITE 17
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER NAME:
FORMER CONFORMED NAME: LIM JONATHAN E
DATE OF NAME CHANGE: 20040310
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Boundless Bio, Inc.
CENTRAL INDEX KEY: 0001782303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 830751369
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9880 CAMPUS POINT DRIVE
STREET 2: SUITE 120
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 766-9912
MAIL ADDRESS:
STREET 1: 9880 CAMPUS POINT DRIVE
STREET 2: SUITE 120
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
ownership.xml
4
X0508
4
2024-04-02
0001782303
Boundless Bio, Inc.
BOLD
0001283290
Lim Jonathan E
C/O BOUNDLESS BIO, INC.
9880 CAMPUS POINT DRIVE, SUITE 120
SAN DIEGO
CA
92121
true
false
false
false
false
Common Stock
2024-04-02
4
C
false
525274
A
550915
I
By City Hill, LLC
Common Stock
102564
D
Series A Convertible Preferred Stock
2024-04-02
4
C
false
512820
D
Common Stock
512820
0
I
By City Hill, LLC
Series B Convertible Preferred Stock
2024-04-02
4
C
false
5128
D
Common Stock
5128
0
I
By City Hill, LLC
Series C Convertible Preferred Stock
2024-04-02
4
C
false
7326
D
Common Stock
7326
0
I
By City Hill, LLC
Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.
Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein.
/s/ Jessica Oien, Attorney-in-Fact for Jonathan Lim
2024-04-04